Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 24751611)

1.

Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries.

Abdel-Aziz AK, Shouman S, El-Demerdash E, Elgendy M, Abdel-Naim AB.

Chem Biol Interact. 2014 Jun 25;217:28-40. doi: 10.1016/j.cbi.2014.04.007. Epub 2014 Apr 18.

PMID:
24751611
2.

Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.

Ping SY, Wu CL, Yu DS.

Urol Oncol. 2012 Sep;30(5):652-9. doi: 10.1016/j.urolonc.2010.07.001. Epub 2010 Sep 29.

PMID:
20884251
3.

Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

Lopergolo A, Nicolini V, Favini E, Dal Bo L, Tortoreto M, Cominetti D, Folini M, Perego P, Castiglioni V, Scanziani E, Borrello MG, Zaffaroni N, Cassinelli G, Lanzi C.

J Clin Endocrinol Metab. 2014 Feb;99(2):498-509. doi: 10.1210/jc.2013-2574. Epub 2013 Nov 25.

PMID:
24276455
4.

Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.

Wu CL, Ping SY, Yu CP, Yu DS.

Kaohsiung J Med Sci. 2012 Apr;28(4):194-203. doi: 10.1016/j.kjms.2011.06.020. Epub 2011 Sep 25.

PMID:
22453067
5.

Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.

Castillo-Avila W, Piulats JM, Garcia Del Muro X, Vidal A, Condom E, Casanovas O, Mora J, Germà JR, Capellà G, Villanueva A, Viñals F.

Clin Cancer Res. 2009 May 15;15(10):3384-95. doi: 10.1158/1078-0432.CCR-08-2170. Epub 2009 May 5.

6.

Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.

Saraswati S, Agrawal SS, Alhaider AA.

Chem Biol Interact. 2013 Nov 25;206(2):153-65. doi: 10.1016/j.cbi.2013.09.004. Epub 2013 Sep 17.

PMID:
24051192
7.

Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma.

Huynh H, Ngo VC, Choo SP, Poon D, Koong HN, Thng CH, Toh HC, Zheng L, Ong LC, Jin Y, Song IC, Chang AP, Ong HS, Chung AY, Chow PK, Soo KC.

Curr Cancer Drug Targets. 2009 Sep;9(6):738-47.

PMID:
19754358
8.

Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer.

Awasthi N, Zhang C, Ruan W, Schwarz MA, Schwarz RE.

PLoS One. 2012;7(6):e38477. doi: 10.1371/journal.pone.0038477. Epub 2012 Jun 18.

9.

Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.

Xin H, Zhang C, Herrmann A, Du Y, Figlin R, Yu H.

Cancer Res. 2009 Mar 15;69(6):2506-13. doi: 10.1158/0008-5472.CAN-08-4323. Epub 2009 Feb 24.

10.

Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.

Hatipoglu G, Hock SW, Weiss R, Fan Z, Sehm T, Ghoochani A, Buchfelder M, Savaskan NE, Eyüpoglu IY.

Cancer Sci. 2015 Feb;106(2):160-70. doi: 10.1111/cas.12580. Epub 2015 Feb 15.

PMID:
25458015
11.

Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells.

Ketola K, Kallioniemi O, Iljin K.

PLoS One. 2012;7(12):e51470. doi: 10.1371/journal.pone.0051470. Epub 2012 Dec 12.

12.

Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways.

Lyros O, Mueller A, Heidel F, Schimanski CC, Gockel I, Galle PR, Lang H, Moehler M.

Int J Cancer. 2010 Sep 1;127(5):1197-208. doi: 10.1002/ijc.25137.

PMID:
20039326
13.

Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer.

Brooks C, Sheu T, Bridges K, Mason K, Kuban D, Mathew P, Meyn R.

Radiat Oncol. 2012 Sep 11;7:154. doi: 10.1186/1748-717X-7-154.

14.

Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat pheochromocytoma PC12 cells.

Ikeda T, Ishii KA, Saito Y, Miura M, Otagiri A, Kawakami Y, Shimano H, Hara H, Takekoshi K.

J Pharmacol Sci. 2013;121(1):67-73. Epub 2012 Dec 26.

15.

Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model.

Sonpavde G, Jian W, Liu H, Wu MF, Shen SS, Lerner SP.

Urol Oncol. 2009 Jul-Aug;27(4):391-9. doi: 10.1016/j.urolonc.2008.03.017. Epub 2008 Jun 4.

PMID:
18534874
16.

Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD.

Saito Y, Tanaka Y, Aita Y, Ishii KA, Ikeda T, Isobe K, Kawakami Y, Shimano H, Hara H, Takekoshi K.

Am J Physiol Endocrinol Metab. 2012 Mar 15;302(6):E615-25. doi: 10.1152/ajpendo.00035.2011. Epub 2011 Aug 30.

17.

In vivo antitumor and antimetastatic activity of sunitinib in preclinical neuroblastoma mouse model.

Zhang L, Smith KM, Chong AL, Stempak D, Yeger H, Marrano P, Thorner PS, Irwin MS, Kaplan DR, Baruchel S.

Neoplasia. 2009 May;11(5):426-35.

18.

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

Chahal M, Xu Y, Lesniak D, Graham K, Famulski K, Christensen JG, Aghi M, Jacques A, Murray D, Sabri S, Abdulkarim B.

Neuro Oncol. 2010 Aug;12(8):822-33. doi: 10.1093/neuonc/noq017. Epub 2010 Feb 23.

19.

Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells.

Santoni M, Amantini C, Morelli MB, Liberati S, Farfariello V, Nabissi M, Bonfili L, Eleuteri AM, Mozzicafreddo M, Burattini L, Berardi R, Cascinu S, Santoni G.

Br J Cancer. 2013 Aug 20;109(4):1040-50. doi: 10.1038/bjc.2013.420. Epub 2013 Jul 25.

20.

Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells.

Zhao Y, Xue T, Yang X, Zhu H, Ding X, Lou L, Lu W, Yang B, He Q.

Toxicol Appl Pharmacol. 2010 Oct 1;248(1):20-7. doi: 10.1016/j.taap.2010.07.007. Epub 2010 Jul 15.

PMID:
20637791
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk